Positive Association Between IL-16 rs11556218 T/G Polymorphism and Cancer Risk: a Meta-analysis |
Mo, Cui-Ju
(Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University)
Peng, Qi-Liu (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) He, Yu (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) Wang, Jian (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) Xie, Li (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) Li, Tai-Jie (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) Li, Shan (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) Qin, Xue (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) |
1 | Alexandrakis MG, Passam FH, Kyriakou DS, et al (2004). Serum level of interleukin-16 in multiple myeloma patients and its relationship to disease activity. Am J Hematol, 75, 101-6. DOI |
2 | Almendro V, Marusyk A, Polyak K (2013). Cellular heterogeneity and molecular evolution in cancer. Annu Rev Pathol, 8, 277-302. DOI |
3 | Azimzadeh P, Romani S, Mohebbi SR, et al (2011). Interleukin-16 (IL-16) gene polymorphisms in Iranian patients with colorectal cancer. J Gastrointestin Liver Dis, 20, 371-6. |
4 | Azimzadeh P, Romani S, Mohebbi SR, et al (2012). Association of polymorphisms in microRNA-binding sites and colorectal cancer in an Iranian population. Cancer Genet, 205, 501-7. DOI ScienceOn |
5 | Baier M, Bannert N, Werner A, et al (1997). Molecular cloning, sequence, expression, and processing of the interleukin 16 precursor. Proc Natl Acad Sci USA, 94, 5273-7. DOI |
6 | Balkwill F, Mantovani A (2001). Inflammation and cancer: back to Virchow? Lancet, 357, 539-45. DOI ScienceOn |
7 | Batai K, Shah E, Murphy AB, et al (2012). Fine-mapping of IL16 gene and prostate cancer risk in African Americans. Cancer Epidemiol Biomarkers Prev, 21, 2059-68. DOI |
8 | Bredberg A (2011). Cancer: more of polygenic disease and less of multiple mutations? A quantitative viewpoint. Cancer, 117, 440-5. DOI |
9 | Drwinga HL, Toji LH, Kim CH, et al (1993). NIGMS human/rodent somatic cell hybrid mapping panels 1 and 2. Genomics, 16, 311-4. DOI |
10 | Center DM, Cruikshank W (1982). Modulation of lymphocyte migration by human lymphokines. I. Identification and characterization of chemoattractant activity for lymphocytes from mitogen-stimulated mononuclear cells. J Immunol, 128, 2563-8. |
11 | Center DM, Kornfeld HCruikshank WW (1996). Interleukin 16 and its function as a CD4 ligand. Immunol Today, 17, 476-81. DOI ScienceOn |
12 | Deng Y, Li RL, Huang XM, et al (2012). Genetic polymorphism of interleukin-16 influences susceptibility of hepatocellular carcinoma. J Practical Medicine, 28, 3910-2. |
13 | Du YJ, Yin CJ, Zhu J, et al (2012). Correlation between IL-16 gene- 295 T>C polymorphism and risk of renal cell carcinoma. J CIin Med in Practice, 16, 18-21. |
14 | Gao LB, Liang WB, Xue H, et al (2009a). Genetic polymorphism of interleukin-16 and risk of nasopharyngeal carcinoma. Clin Chim Acta, 409, 132-5. DOI ScienceOn |
15 | Gao LB, Rao L, Wang YY, et al (2009b). The association of interleukin-16 polymorphisms with IL-16 serum levels and risk of colorectal and gastric cancer. Carcinogenesis, 30, 295-9. |
16 | Hughes L, Ruth K, Rebbeck TR, et al (2013). Genetic variation in IL-16 miRNA target site and time to prostate cancer diagnosis in African-American men. Prostate Cancer Prostatic Dis, 16, 308-14. DOI |
17 | Kai H, Kitadai Y, Kodama M, et al (2005). Involvement of proinflammatory cytokines IL-1beta and IL-6 in progression of human gastric carcinoma. Anticancer Res, 25, 709-13. |
18 | Hussain SP, Harris CC (2007). Inflammation and cancer: an ancient link with novel potentials. Int J Cancer, 121, 2373-80. DOI ScienceOn |
19 | Jim HS, Park JY, Permuth-Wey J, et al (2012). Genetic predictors of fatigue in prostate cancer patients treated with androgen deprivation therapy: preliminary findings. Brain Behav Immun, 26, 1030-6. DOI |
20 | Li S, Deng Y, Chen ZP, et al (2011). Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population. Infect Genet Evol, 11, 2083-8. DOI ScienceOn |
21 | Kimman M, Norman R, Jan S, et al (2012). The burden of cancer in member countries of the Association of Southeast Asian Nations (ASEAN). Asian Pac J Cancer Prev, 13, 411-20. 과학기술학회마을 DOI |
22 | Kovacs E (2001). The serum levels of IL-12 and IL-16 in cancer patients. Relation to the tumour stage and previous therapy. Biomed Pharmacother, 55, 111-6. DOI |
23 | Lin PC, Liu TC, Chang CC, et al (2012). High-resolution melting (HRM) analysis for the detection of single nucleotide polymorphisms in microRNA target sites. Clin Chim Acta, 413, 1092-7. DOI |
24 | Mantovani A (2005). Cancer: inflammation by remote control. Nature, 435, 752-3. DOI ScienceOn |
25 | Mathy NL, Scheuer W, Lanzendorfer M, et al (2000). Interleukin-16 stimulates the expression and production of pro-inflammatory cytokines by human monocytes. Immunology, 100, 63-9. DOI |
26 | Shanmugham LN, Petrarca C, Frydas S, et al (2006). IL-15 an immunoregulatory and anti-cancer cytokine. Recent advances. J Exp Clin Cancer Res, 25, 529-36. |
27 | Muc-Wierzgon M, Nowakowska-Zajdel E, Kokot T, et al (2006). Genetic disregulation of TNF alpha and TNF alpha type II receptors in colon cancer at the II and III stage of disease. J Biol Regul Homeost Agents, 20, 10-4. |
28 | Nakayama EE, Wasi C, Ajisawa A, et al (2000). A new polymorphism in the promoter region of the human interleukin-16 (IL-16) gene. Genes Immun, 1, 293-4. DOI |
29 | Obara W (2010). Editorial comment to IL-16 polymorphism and risk of renal cell carcinoma: association in a Chinese population. Int J Urol, 17, 707. DOI |
30 | Qin X, Peng Q, Lao XX, et al (2014). The association of interleukin-16 gene polymorphisms with IL-16 serum levels and risk of nasopharyngeal carcinoma in a Chinese population. Tumour Biol, 35, 1917-24. DOI |
31 | Quinn GP, Pal T, Murphy D, et al (2012). High-risk consumers' perceptions of preimplantation genetic diagnosis for hereditary cancers: a systematic review and meta-analysis. Genet Med, 14, 191-200. DOI |
32 | Thomas G, Jacobs KB, Yeager M, et al (2008). Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet, 40, 310-5. DOI ScienceOn |
33 | van Horssen R, Ten Hagen TL, Eggermont AM (2006). TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility. Oncologist, 11, 397-408. DOI ScienceOn |
34 | Weiderpass E (2010). Lifestyle and cancer risk. J Prev Med Public Health, 43, 459-71. DOI ScienceOn |
35 | Zhu J, Qin C, Yan F, et al (2010). IL-16 polymorphism and risk of renal cell carcinoma: association in a Chinese population. Int J Urol, 17, 700-7. DOI ScienceOn |
36 | Zhao J, Yang YM, Li QZ (2012). Association between IL-16 polymorphisms and risk of cervical cancer. Chin J Cancer Prev Treat, 19, 1205-20. |
37 | Zhang T, Wang H (2013). Variants of interleukin-16 associated with gastric cancer risk. Asian Pac J Cancer Prev, 14, 5269-73. 과학기술학회마을 DOI ScienceOn |
38 | Zhang Y, Center DM, Wu DM, et al (1998). Processing and activation of pro-interleukin-16 by caspase-3. J Biol Chem, 273, 1144-9. DOI |
39 | Sethi G, Shanmugam MK, Ramachandran L, et al (2012). Multifaceted link between cancer and inflammation. Biosci Rep, 32, 1-15. DOI |